skip navigation



NOTES:


Source

(Added Pub. L. 98–127, § 4(a), Oct. 13, 1983, 97 Stat. 832; amended Pub. L. 106–113, div. B, § 1000(a)(9) [title IV, § 4732(a)(7), (10)(A)], Nov. 29, 1999, 113 Stat. 1536, 1501A–582; Pub. L. 107–273, div. C, title III, § 13206(b)(1)(B), Nov. 2, 2002, 116 Stat. 1906.)

References in Text

Section 505(b)(1) of the Federal Food, Drug and Cosmetic Act, referred to in subsec. (a)(1)(A), is classified to section 355 (b)(1) of Title 21, Food and Drugs.
The date of enactment of this section, referred to in subsec. (c), is the date of enactment of Pub. L. 98–127, which was approved Oct. 13, 1983.

Amendments

2002—Subsec. (c). Pub. L. 107–273 made technical correction to directory language of Pub. L. 106–113, § 1000(a)(9) [title IV, § 4732(a)(10)(A)]. See 1999 Amendment note below.
1999—Subsec. (c). Pub. L. 106–113, § 1000(a)(9) [title IV, § 4732(a)(10)(A)], as amended by Pub. L. 107–273, substituted “Director shall confirm” for “Commissioner shall confirm”.
Pub. L. 106–113, § 1000(a)(9) [title IV, § 4732(a)(7)], substituted “notify the Director” for “notify the Commissioner of Patents and Trademarks”.

Effective Date of 1999 Amendment

Amendment by Pub. L. 106–113 effective 4 months after Nov. 29, 1999, see section 1000 (a)(9) [title IV, § 4731] of Pub. L. 106–113, set out as a note under section 1 of this title.


LII has no control over and does not endorse any external Internet site that contains links to or references LII.
Study law abroad: Cornell Paris Institute